E8780
Epiregulin from mouse
recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Synonym(s):
EREG
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
recombinant
expressed in E. coli
Assay
≥97% (SDS-PAGE)
form
lyophilized powder
mol wt
predicted mol wt ~5.5 kDa
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
UniProt accession no.
storage temp.
−20°C
Gene Information
mouse ... Ereg(13874)
Biochem/physiol Actions
Binds and activates the tyrosine kinase ErbB family receptors (ErbB1-ErbB4). Inhibits the growth of several epithelial tumor cells and stimulates the growth of fibroblasts and other cell types. Its expression is upregulated in a number of carcinoma cell lines.
Physical form
Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline containing 0.5 mg bovine serum albumin.
Preparation Note
Recombinant Mouse Epiregulin is produced from a DNA sequence encoding the mature mouse epiregulin protein sequence. The protein is expressed in E. coli.
Epiregulin is a member of EGF (epidermal growth factor) family. All members of the EGF family are synthesized as transmembrane precursors and converted to soluble forms by proteolytic cleavage. Epiregulin was originally purified from the mouse fibroblast-derived tumor cell line NIH3T3/T7. Mouse epiregulin cDNA encodes a transmembrane precursorof 162 amino acids with a mature soluble form consisting of residues 56-101. Epiregulin acts like other EGF family members by binding to and activating the tyrosine kinase ErbB family receptors (ErbB1-ErbB4). Epiregulin has a broad specificity, but this ligand seems to preferentially activate heterodimeric receptor complexes. Epiregulin inhibits the growth of several epithelial tumor cells and stimulates the growth of fibroblasts and other types of cells. Its expression is upregulated in a number of carcinoma cell lines. Epiregulin is also an autocrine growth factor in human epidermal keratinocytes, and involved in the early stages of pregnancy, regulating the attachment of the blastocyst to the uterine epithelium during the implantation process.
Epiregulin is a member of EGF (epidermal growth factor) family. All members of the EGF family are synthesized as transmembrane precursors and converted to soluble forms by proteolytic cleavage. Epiregulin was originally purified from the mouse fibroblast-derived tumor cell line NIH3T3/T7. Mouse epiregulin cDNA encodes a transmembrane precursorof 162 amino acids with a mature soluble form consisting of residues 56-101. Epiregulin acts like other EGF family members by binding to and activating the tyrosine kinase ErbB family receptors (ErbB1-ErbB4). Epiregulin has a broad specificity, but this ligand seems to preferentially activate heterodimeric receptor complexes. Epiregulin inhibits the growth of several epithelial tumor cells and stimulates the growth of fibroblasts and other types of cells. Its expression is upregulated in a number of carcinoma cell lines. Epiregulin is also an autocrine growth factor in human epidermal keratinocytes, and involved in the early stages of pregnancy, regulating the attachment of the blastocyst to the uterine epithelium during the implantation process.
Analysis Note
The biological activity is measured by its ability to stimulate the 3H-thymidine incorporation in a mouse fibroblast cell line, Balb/3T3.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Journal of dermatological science, 24 Suppl 1, S46-S50 (2001-01-04)
Various kinds of growth factors are involved in the regulation of human keratinocyte function. Among them, the epidermal growth factor (EGF) family and the transforming growth factor-beta (TGF-beta) family play central roles, providing dual-mode regulation of keratinocyte growth through the
FEBS letters, 377(3), 403-407 (1995-12-27)
A cDNA clone encoding a novel epidermal growth factor (EGF)-related growth regulator, epiregulin, was isolated from a cDNA library prepared from a mouse fibroblast-derived tumor cell line, NIH3T3/clone T7. The predicted amino acid sequence revealed that the purified epiregulin peptide
Molecular and cellular biochemistry, 398(1-2), 105-113 (2014-09-17)
Epidermal growth factor (EGF) receptor (EGFR) emerges as an essential molecule for the regulating of osteoblast cellular functions. In the current study, we explored the effect of epiregulin, a new EGFR ligand, on osteoblast functions in vitro, and studied the
Cancer research, 48(14), 4083-4092 (1988-07-15)
A completely serum-free assay method has been used to compare the mitogenic activities of polypeptide growth factors and estrogens with MCF-7 and T47D human breast cancer cells in culture. The lines were maintained in a viable, slowly dividing condition in
Endocrine-related cancer, 21(4), 677-690 (2014-06-19)
Estrogens contribute to the development and growth of the prostate and are implicated in prostate tumorigenesis. In their target tissues, estrogens mediate their effects via estrogen receptor α (ERα (ESR1)) and β (ERβ (ESR2)). Hyperplasia and decreased differentiation of epithelial
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service